发明名称 CANCER DRUGS AND USES
摘要 A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.
申请公布号 CA2898113(A1) 申请公布日期 2014.07.17
申请号 CA20142898113 申请日期 2014.01.14
申请人 HEALTH CLINICS LIMITED 发明人 BANNISTER, ROBIN MARK;BREW, JOHN;STOLOFF, GREGORY ALAN
分类号 A61K31/357;A61K31/05;A61K31/155;A61K31/352;A61K31/366;A61K31/4184;A61K31/517;A61K31/7068;A61P35/00 主分类号 A61K31/357
代理机构 代理人
主权项
地址